Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
| Company Name | Founded | Funding Stage | Amount | City |
|---|---|---|---|---|
| Quench Bio | 2020 | Series A | $50.0M | Cambridge |
| # | Company | Stage | Amount | Location |
|---|---|---|---|---|
| 426 | Quench Bio | Series A | $50.0M | Cambridge, United States |
| 427 | Prevail Therapeutics | Series B | $50.0M | New York, United States |
| 428 | Peloton Therapeutics | Series E | $150.0M | Dallas, United States |
| 429 | Crescent Pass Energy | Private Equity | $75.0M | Houston, United States |
| 430 | Attune Pharmaceuticals | Series B | $23.0M | New York, United States |
| 431 | Sojournix | Series C | $44.0M | Arlington, United States |
| 432 | WhiteSwell | Series B | $30.0M | Ballybrit, Ireland |
| 433 | CiVi Biopharma | Series Unknown | $49.0M | Chevy Chase, United States |
| 434 | Medeor Therapeutics | Grant | $18.8M | South San Francisco, United States |
| 435 | Braeburn | Debt Financing | $110.0M | Plymouth Meeting, United States |
Quench Bio is a developer of gasdermin biology drugs designed to treat severe inflammatory diseases.
Prevail Therapeutics is a biotechnology company focused on developing novel gene therapies for patients with Parkinson’s disease.
Peloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.
Crescent Pass Energy is an oil and gas company based in Houston, Texas.
Attune Pharmaceuticals is a private biotechnology company.
Sojournix is a biotechnology company developing innovative medicines for women's health and endocrine disorders.
WhiteSwell is dedicated to advancing treatment of acute decompensated heart failure .
CiVi Biopharma is a clinical stage research and development biotechnology company whose mission is to create novel cardiovascular.
Medeor Therapeutics is a biotechnology company that dedicates to dedicates to the development of personalized cellular immunotherapies.
We transform the management of OUD to help people begin and sustain recovery.
Adeo Health Science is consumer health and biotechnology company, focusing on improving immune health in infants
OvaScience is a life sciences company focused on the discovery, development and commercialization of treatments for infertility.
Antera Therapeutics is creating therapies that will prevent allergy development in children.
Lumena Pharmaceuticals develops oral therapeutics for rare liver diseases to improve liver function and relieve disease symptoms.
RA Capital Management has invested in 439 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
RA Capital Management's top investment sectors include Biotechnology, Health Care, Pharmaceutical, Therapeutics, Medical Device. The firm invests across 13 different industry categories.
Among tracked funding rounds, Peloton Therapeutics received $150.0M in a Series E round. RA Capital Management's total known invested capital is $19.0B.
RA Capital Management's average investment size is $91.5M across its portfolio of 439 companies.
Recent RA Capital Management portfolio additions include Quench Bio. These companies were founded in 2020 or later.
Discover portfolio companies of other leading venture capital firms and investors.
View All Investors